Last reviewed · How we verify
Topical L. crispatus Treatment Group — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Topical L. crispatus Treatment Group (Topical L. crispatus Treatment Group) — Shenzhen People's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topical L. crispatus Treatment Group TARGET | Topical L. crispatus Treatment Group | Shenzhen People's Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topical L. crispatus Treatment Group CI watch — RSS
- Topical L. crispatus Treatment Group CI watch — Atom
- Topical L. crispatus Treatment Group CI watch — JSON
- Topical L. crispatus Treatment Group alone — RSS
Cite this brief
Drug Landscape (2026). Topical L. crispatus Treatment Group — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-l-crispatus-treatment-group. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab